Jed G. Nuchtern

10.8k total citations · 3 hit papers
153 papers, 7.1k citations indexed

About

Jed G. Nuchtern is a scholar working on Surgery, Neurology and Oncology. According to data from OpenAlex, Jed G. Nuchtern has authored 153 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Surgery, 53 papers in Neurology and 41 papers in Oncology. Recurrent topics in Jed G. Nuchtern's work include Neuroblastoma Research and Treatments (48 papers), Neuroendocrine Tumor Research Advances (15 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Jed G. Nuchtern is often cited by papers focused on Neuroblastoma Research and Treatments (48 papers), Neuroendocrine Tumor Research Advances (15 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Jed G. Nuchtern collaborates with scholars based in United States, China and Canada. Jed G. Nuchtern's co-authors include Richard D. Klausner, Malcolm K. Brenner, William E. Biddison, Sanjeev A. Vasudevan, Margaret A. Goodell, Angela E. Foster, Thomas Jax, U. Göbel, Gerald Wulf and Mary L. Brandt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jed G. Nuchtern

151 papers receiving 7.0k citations

Hit Papers

A distinct “side population” of cells with high drug effl... 2004 2026 2011 2018 2004 2008 2021 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jed G. Nuchtern United States 41 2.5k 2.2k 2.0k 1.7k 1.2k 153 7.1k
Alberto Garaventa Italy 43 2.4k 0.9× 1.7k 0.8× 4.4k 2.2× 1.2k 0.7× 1.9k 1.6× 251 7.0k
Clara C. Chen United States 46 1.2k 0.5× 3.3k 1.5× 936 0.5× 2.6k 1.5× 2.1k 1.8× 99 8.9k
Bruce Pawel United States 36 2.2k 0.9× 1.3k 0.6× 908 0.5× 813 0.5× 984 0.8× 139 5.1k
Robert B. Gerbing United States 51 4.6k 1.8× 2.1k 1.0× 5.3k 2.7× 826 0.5× 2.1k 1.8× 239 11.0k
Katsuyuki Aozasa Japan 58 3.3k 1.3× 4.7k 2.1× 980 0.5× 1.6k 0.9× 1.0k 0.9× 311 11.4k
Timothy C. Greiner United States 41 1.3k 0.5× 3.0k 1.3× 824 0.4× 1.1k 0.6× 767 0.7× 138 7.7k
Victor M. Santana United States 43 2.0k 0.8× 2.0k 0.9× 1.6k 0.8× 568 0.3× 479 0.4× 148 5.4k
Christopher Poremba Germany 54 3.0k 1.2× 2.5k 1.2× 513 0.3× 1.3k 0.8× 1.8k 1.6× 166 7.7k
Meinoshin Okumura Japan 55 1.5k 0.6× 2.4k 1.1× 3.1k 1.6× 2.4k 1.4× 757 0.6× 346 10.3k
Suzanne George United States 55 1.8k 0.7× 3.7k 1.7× 1.4k 0.7× 2.1k 1.2× 978 0.8× 257 11.7k

Countries citing papers authored by Jed G. Nuchtern

Since Specialization
Citations

This map shows the geographic impact of Jed G. Nuchtern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jed G. Nuchtern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jed G. Nuchtern more than expected).

Fields of papers citing papers by Jed G. Nuchtern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jed G. Nuchtern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jed G. Nuchtern. The network helps show where Jed G. Nuchtern may publish in the future.

Co-authorship network of co-authors of Jed G. Nuchtern

This figure shows the co-authorship network connecting the top 25 collaborators of Jed G. Nuchtern. A scholar is included among the top collaborators of Jed G. Nuchtern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jed G. Nuchtern. Jed G. Nuchtern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuchtern, Jed G., et al.. (2025). Predicting In-hospital Mortality of Pediatric Surgical Admissions in Central Malawi. Journal of Pediatric Surgery. 60(6). 162167–162167. 1 indexed citations
2.
Brown, Erin G., E. Stanton Adkins, Peter Mattei, et al.. (2024). Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. Journal of Pediatric Surgery. 60(1). 161896–161896. 1 indexed citations
3.
Shaffiey, Shahab, Hau D. Le, Emily Christison‐Lagay, et al.. (2023). Critical elements of pediatric neuroblastoma surgery. Seminars in Pediatric Surgery. 32(5). 151338–151338. 5 indexed citations
4.
Tomoka, Tamiwe, Ruth Namazzi, Parth S. Mehta, et al.. (2023). Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities. Pediatric Blood & Cancer. 70(5). e30242–e30242. 5 indexed citations
5.
Mehl, Steven C., Brittany Johnson, Nihar Patel, et al.. (2022). Comparison of subcutaneous analgesic system and epidural analgesia for postoperative pain control in open pediatric oncology operations: A randomized controlled trial. Journal of Pediatric Surgery. 58(1). 153–160. 5 indexed citations
6.
Mehl, Steven C., Raphael C. Sun, Andres F. Espinoza, et al.. (2022). Association of Intercostal Nerve Cryoablation During Nuss Procedure With Complications and Costs. The Annals of Thoracic Surgery. 116(4). 803–809. 12 indexed citations
7.
Mehl, Steven C., Richard S. Whitlock, Sanjeev A. Vasudevan, et al.. (2021). Thoracoscopic Resection of Thoracic Inlet Neuroblastic Tumors in Young Children. Journal of Laparoendoscopic & Advanced Surgical Techniques. 31(12). 1475–1479. 2 indexed citations
8.
Whitlock, Richard S., Sarah Jane Commander, Huirong Zhu, et al.. (2021). Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. Journal of Pediatric Surgery. 57(8). 1544–1553. 5 indexed citations
9.
Nuchtern, Jed G., et al.. (2021). Management of Neuroblastoma in Pediatric Patients. Surgical Oncology Clinics of North America. 30(2). 291–304. 27 indexed citations
10.
Whittle, Sarah Burkhead, Valeria Smith, Allison Silverstein, et al.. (2020). Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatric Blood & Cancer. 67(10). e28417–e28417. 3 indexed citations
11.
Yu, Yang, Yanling Zhao, Yihui Fan, et al.. (2019). Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma. Molecular Cancer Therapeutics. 18(6). 1045–1056. 13 indexed citations
12.
Campagna, Giovanni, Eric H. Rosenfeld, Jennifer H. Foster, et al.. (2018). Evolving biopsy techniques for the diagnosis of neuroblastoma in children. Journal of Pediatric Surgery. 53(11). 2235–2239. 25 indexed citations
13.
Richards, Morgan K., Adam B. Goldin, Elizabeth A. Beierle, et al.. (2017). Breast Malignancies in Children: Presentation, Management, and Survival. Annals of Surgical Oncology. 24(6). 1482–1491. 16 indexed citations
14.
Rojas, Yesenia, Bethany J. Slater, Michael Baker, et al.. (2016). Childhood and adolescent tracheobronchial mucoepidermoid carcinoma (MEC): a case-series and review of the literature. Pediatric Surgery International. 32(4). 417–424. 12 indexed citations
15.
Rojas, Yesenia, Wei Zhang, Elizabeth A. Beierle, et al.. (2015). Primary malignant pulmonary tumors in children: a review of the national cancer data base. Journal of Pediatric Surgery. 50(6). 1004–1008. 42 indexed citations
16.
Baxter, Patricia, Patrick A. Thompson, Brian Gibson, et al.. (2010). Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemotherapy and Pharmacology. 67(4). 809–812. 5 indexed citations
17.
Shang, Xiaoying, Susan M. Burlingame, M. Fatih Okcu, et al.. (2009). Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Molecular Cancer Therapeutics. 8(8). 2461–2469. 79 indexed citations
18.
Vasudevan, Sanjeev A., Ningling Ge, Heidi V. Russell, et al.. (2009). Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Molecular Cancer Therapeutics. 8(8). 2478–2489. 10 indexed citations
19.
Zhang, Linna, Sharon E. Plon, Jed G. Nuchtern, et al.. (2004). Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines. Anti-Cancer Drugs. 15(9). 883–888. 5 indexed citations
20.
Brandt, Mary L., et al.. (2002). Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney International. 62(5). 1864–1869. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026